A.L. de Weck - Concepedia

Author

A.L. de Weck

Also Known As

A L DE WECK, A L De Weck, A L de Weck, A. L. DE WECK, A. L. De Weck, A. L. Weck, A. L. de WECK, A. L. de Weck, A.L de Weck, A.L. DE WECK

222

Publications

5.7K

Citations

H-Index

136

Concepts

All Affiliations

University Hospital of Bern University of Bern Universidad de Navarra Roche (Switzerland)Clinica Universidad de Navarra

About

A.L. de Weck is an author at University Hospital of Bern specializing in medicine, allergy, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	63	3.4K
2	Natural Sciences	10	10	323
3	Health Sciences	7	7	337
4	Engineering	4	4	93
5	Education	2	2	75

A.L. de Weck

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. T Guthe, R. R. Willcox, A.L. de Weck PubMed AsthmaEnvironmental AllergyAllergy MedicineAllergenDrug Allergy	1968	547
Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate‐type reactions to betalactam antibiotics M L Sánz, Pedro Gamboa, I. Antépara, Clinical & Experimental Allergy	2002	267
Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. Stephan C. Bischoff, Thomas Brunner, A.L. de Weck, The Journal of Experimental Medicine ImmunologyImmune RegulationInnate ImmunityImmunotherapyInflammation	1990	214
Interleukin 3-dependent mediator release in basophils triggered by C5a. Y Kurimoto, A.L. de Weck, Clemens A. Dahinden The Journal of Experimental Medicine Lung InflammationImmunologyImmune RegulationInnate ImmunityImmune System	1989	204
Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals. Clemens A. Dahinden, Jean‐Marc Zingg, Friedrich E. Maly, The Journal of Experimental Medicine Lipid PeroxidationImmunologyBlood CellImmune SystemOxidative Stress	1988	185
The neutrophil-activating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin 3-primed basophils. Clemens A. Dahinden, Y Kurimoto, A.L. de Weck, The Journal of Experimental Medicine ImmunologyInnate ImmunityDermatologyRelease HistamineImmunotherapy	1989	181
Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a. S.C. Bischoff, A.L. de Weck, C. A. Dahinden Proceedings of the National Academy of Sciences Complement Component C3aCellular ImmunologyImmunologyImmune RegulationSmooth Muscle Contraction	1990	156
Superoxide-dependent nitroblue tetrazolium reduction and expression of cytochrome <i>b</i>-245 components by human tonsillar B lymphocytes and B cell lines. F.E. Maly, Michio Nakamura, J F Gauchat, The Journal of Immunology	1989	139
The flow‐cytometric determination of basophil activation induced by aspirin and other non‐steroidal anti‐inflammatory drugs (NSAIDs) is useful for <i>in vitro</i> diagnosis of the NSAID hypersensitivity syndrome P. Gamboa, M L Sánz, M. Rosario Caballero, Clinical & Experimental Allergy	2004	127
Use of CD63 expression as a marker of <i>in vitro</i> basophil activation and leukotriene determination in metamizol allergic patients Pedro Gamboa, M L Sánz, M. Rosario Caballero, Allergy	2003	108

Page 1